Wagner, J., Štibi, S., Selak, N., Alvir, I., Mamić, I., Marcelić, L. ... Danolić, D. (2023). Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer. Wiener Medizinische Wochenschrift, 173. (3-4), 57-61. doi: 10.1007/s10354-021-00907-w
Wagner, Jasenka, et al. "Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer." Wiener Medizinische Wochenschrift, vol. 173, no. 3-4, 2023, pp. 57-61. https://doi.org/10.1007/s10354-021-00907-w
Wagner, Jasenka, Sanela Štibi, Nikica Selak, Ilija Alvir, Ivica Mamić, Luka Marcelić, Lucija Šušnjar, Mario Puljiz, Marija Heffer and Damir Danolić. "Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer." Wiener Medizinische Wochenschrift 173, no. 3-4 (2023): 57-61. https://doi.org/10.1007/s10354-021-00907-w
Wagner, J., et al. (2023) 'Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer', Wiener Medizinische Wochenschrift, 173(3-4), pp. 57-61. doi: 10.1007/s10354-021-00907-w
Wagner J, Štibi S, Selak N, Alvir I, Mamić I, Marcelić L, and sur.. Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer. Wiener Medizinische Wochenschrift [Internet]. 2023 [cited 2025 February 13];173(3-4):57-61. doi: 10.1007/s10354-021-00907-w
J. Wagner, et al., "Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer", Wiener Medizinische Wochenschrift, vol. 173, no. 3-4, pp. 57-61, 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:220:505863. [Accessed: 13 February 2025]